Robert D Daniels1, Stephen Bertke, Kathleen M Waters, Mary K Schubauer-Berigan. 1. National Institute for Occupational Safety and Health (NIOSH), Division of Surveillance, Hazard Evaluations, and Field Studies (DSHEFS), Industrywide Studies Branch (IWSB), Cincinnati, OH 45226, USA. rtd2@cdc.gov
Abstract
OBJECTIVE: To follow-up on earlier studies of the leukaemogenicity of occupational ionising radiation exposure. METHODS: We conducted a nested case-control analysis of leukaemia mortality in a pooled cohort of US nuclear workers followed through 2005. Each case was matched to four controls on attained age. Exposures were estimated from available records. General relative risk models were used to estimate the excess relative risk (ERR) of leukaemia, excluding chronic lymphocytic (CLL), acute myeloid leukaemia, chronic myeloid leukaemia and CLL while controlling for potential confounders. Preferred exposure lags and time-windows of risks were calculated using joint maximum likelihood. Dose-response was also examined using linear, linear-quadratic, categorical and restricted cubic spline models. RESULTS: There were 369 leukaemia deaths in 105 245 US nuclear workers. The adjusted ERR for non-CLL leukaemia was 0.09 (95% CI -0.17 to 0.65) per 100 mGy. Elevated non-CLL risks were observed from exposures occurring 6-14 years prior to attained age of cases (ERR per 100 mGy=1.9; 95% CI <0 to 8.0). Lagged models indicated non-linearity of risk at very low (<10 mGy) and high (>100 mGy) doses, which contributed to the imprecision of results in linear models. Similar risk attenuation was not evident in time-windows-based models. CONCLUSIONS: Risk estimates were in reasonable agreement with previous estimates, with the temporality of non-CLL leukaemia risk as a dominant factor in dose-response analyses. Future research should focus on methods that improve evaluations of the dose-response, particularly in the low-dose range.
OBJECTIVE: To follow-up on earlier studies of the leukaemogenicity of occupational ionising radiation exposure. METHODS: We conducted a nested case-control analysis of leukaemia mortality in a pooled cohort of US nuclear workers followed through 2005. Each case was matched to four controls on attained age. Exposures were estimated from available records. General relative risk models were used to estimate the excess relative risk (ERR) of leukaemia, excluding chronic lymphocytic (CLL), acute myeloid leukaemia, chronic myeloid leukaemia and CLL while controlling for potential confounders. Preferred exposure lags and time-windows of risks were calculated using joint maximum likelihood. Dose-response was also examined using linear, linear-quadratic, categorical and restricted cubic spline models. RESULTS: There were 369 leukaemia deaths in 105 245 US nuclear workers. The adjusted ERR for non-CLL leukaemia was 0.09 (95% CI -0.17 to 0.65) per 100 mGy. Elevated non-CLL risks were observed from exposures occurring 6-14 years prior to attained age of cases (ERR per 100 mGy=1.9; 95% CI <0 to 8.0). Lagged models indicated non-linearity of risk at very low (<10 mGy) and high (>100 mGy) doses, which contributed to the imprecision of results in linear models. Similar risk attenuation was not evident in time-windows-based models. CONCLUSIONS: Risk estimates were in reasonable agreement with previous estimates, with the temporality of non-CLL leukaemia risk as a dominant factor in dose-response analyses. Future research should focus on methods that improve evaluations of the dose-response, particularly in the low-dose range.
Authors: John D Boice; Sarah S Cohen; Michael T Mumma; Elizabeth Dupree Ellis; Keith F Eckerman; Richard W Leggett; Bruce B Boecker; A Bertrand Brill; Brian E Henderson Journal: Radiat Res Date: 2006-07 Impact factor: 2.841
Authors: E Cardis; M Vrijheid; M Blettner; E Gilbert; M Hakama; C Hill; G Howe; J Kaldor; C R Muirhead; M Schubauer-Berigan; T Yoshimura; F Bermann; G Cowper; J Fix; C Hacker; B Heinmiller; M Marshall; I Thierry-Chef; D Utterback; Y-O Ahn; E Amoros; P Ashmore; A Auvinen; J-M Bae; J Bernar; A Biau; E Combalot; P Deboodt; A Diez Sacristan; M Eklöf; H Engels; G Engholm; G Gulis; R R Habib; K Holan; H Hyvonen; A Kerekes; J Kurtinaitis; H Malker; M Martuzzi; A Mastauskas; A Monnet; M Moser; M S Pearce; D B Richardson; F Rodriguez-Artalejo; A Rogel; H Tardy; M Telle-Lamberton; I Turai; M Usel; K Veress Journal: Radiat Res Date: 2007-04 Impact factor: 2.841
Authors: Mary K Schubauer-Berigan; Robert D Daniels; Donald A Fleming; Andrea M Markey; James R Couch; Steven H Ahrenholz; Jenneh S Burphy; Jeri L Anderson; Chih-Yu Tseng Journal: Br J Haematol Date: 2007-10-06 Impact factor: 6.998
Authors: Mary K Schubauer-Berigan; Robert D Daniels; Donald A Fleming; Andrea M Markey; James R Couch; Steven H Ahrenholz; Jenneh S Burphy; Jeri L Anderson; Chih-Yu Tseng Journal: Radiat Res Date: 2007-02 Impact factor: 2.841
Authors: Robert D Daniels; Stephen J Bertke; David B Richardson; Elisabeth Cardis; Michael Gillies; Jacqueline A O'Hagan; Richard Haylock; Dominique Laurier; Klervi Leuraud; Monika Moissonnier; Isabelle Thierry-Chef; Ausrele Kesminiene; Mary K Schubauer-Berigan Journal: Int J Cancer Date: 2017-03-15 Impact factor: 7.396
Authors: Robert D Daniels; Stephen Bertke; Matthew M Dahm; James H Yiin; Travis L Kubale; Thomas R Hales; Dalsu Baris; Shelia H Zahm; James J Beaumont; Kathleen M Waters; Lynne E Pinkerton Journal: Occup Environ Med Date: 2015-02-11 Impact factor: 4.402
Authors: I Thierry-Chef; D B Richardson; R D Daniels; M Gillies; G B Hamra; R Haylock; A Kesminiene; D Laurier; K Leuraud; M Moissonnier; J O'Hagan; M K Schubauer-Berigan; E Cardis Journal: Radiat Res Date: 2015-05-26 Impact factor: 2.841
Authors: Sharon R Silver; Stephen J Bertke; Misty Jena Hein; Robert D Daniels; Donald A Fleming; Jeri L Anderson; Susan M Pinney; Richard W Hornung; Chih-Yu Tseng Journal: Occup Environ Med Date: 2013-01-15 Impact factor: 4.402
Authors: Robert D Daniels; Gerald M Kendall; Isabelle Thierry-Chef; Martha S Linet; Harry M Cullings Journal: J Natl Cancer Inst Monogr Date: 2020-07-01
Authors: Mary K Schubauer-Berigan; Amy Berrington de Gonzalez; Elisabeth Cardis; Dominique Laurier; Jay H Lubin; Michael Hauptmann; David B Richardson Journal: J Natl Cancer Inst Monogr Date: 2020-07-01